Oil prices moved higher this week and a jump in gasoline prices could mean more pain at the pump for U.S. consumers.
U.S. Gasoline Fund (NYSEArca: UGA) was on track for a weekly gain of nearly 6%.
Conversely, biotech ETFs were mauled this week. The funds are cooling off after the sector was one of the best performers for 2012.
Volatility-linked funds were also hit by a lower VIX.
The top three unleveraged ETFs this week were U.S. Gasoline Fund, VelocityShares Daily Inverse VIX Short Term (XIV) and ProShares Short VIX Short-Term Futures (SVXY). They were on track for gains of more than 3%.
The bottom three unleveraged ETFs were SPDR S&P Biotech (XBI), First Trust Amex Biotech (FBT) and U.S. Natural Gas (UNG) with losses of at least 4%.
In next week’s economic data, look for reports on consumer credit, the trade deficit and the federal budget. Federal Reserve Chairman Ben Bernanke is scheduled to speak on Monday.
U.S. Gasoline Fund
